Immunotherapy: Neuroblastoma as a Model
- 1 April 1991
- journal article
- review article
- Published by Elsevier in Pediatric Clinics of North America
- Vol. 38 (2) , 425-441
- https://doi.org/10.1016/s0031-3955(16)38085-3
Abstract
No abstract availableKeywords
This publication has 49 references indexed in Scilit:
- Tumor-infiltrating lymphocytes from nonrenal urological malignanciesCancer Immunology, Immunotherapy, 1990
- An Acquired Chemotactic Defect in Neutrophils from Patients Receiving Interleukin-2 ImmunotherapyNew England Journal of Medicine, 1990
- Lysis of neuroblastoma cells by the ADCC-reaction: granulocytes of patients with chronic granulomatous disease are more effective than those of healthy donorsImmunology Letters, 1989
- A phase-II study of adoptive immunotherapy with continuous infusion of interleukin-2 in children with advanced neuroblastoma. A report on 11 casesCancer Treatment Reviews, 1989
- Effect of Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor on Chemotherapy-Induced MyelosuppressionNew England Journal of Medicine, 1988
- Lymphokine-activated killer cell lysis of human neuroblastoma cells: A model for purging tumor cells from bone marrowClinical Immunology and Immunopathology, 1988
- Association of Multiple Copies of the N-mycOncogene with Rapid Progression of NeuroblastomasNew England Journal of Medicine, 1985
- Biologic Differences between Neuroblastoma Stages IV-S and IVNew England Journal of Medicine, 1981
- Studies of the mechanism of regression of human neuroblastomaJournal of Pediatric Surgery, 1968
- Lymphoid infiltrates in neuroblastomas: Their occurrence and prognostic significanceJournal of Pediatric Surgery, 1968